
Dr Agarwal's Hea Q4 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
See what Dr Agarwal's Hea management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Dr Agarwal's Hea management said on order book — free account, 30 seconds.
Capex plans
Track Dr Agarwal's Hea — get its next earnings analysis in your feed
How does Dr Agarwal's Hea rank vs peers in Healthcare Services?
Pro featureHow does Dr Agarwal's Hea rank in Healthcare Services?
Compare Dr Agarwal's Hea against every Healthcare Services company (Q4 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Dr Agarwal's Hea's management said in earlier quarters
- Q2 FY27 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
Earlier calls (1)
Others in Healthcare Services this season
- Chandan Healthca (Q2 FY27)
Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor
- Invicta Diagnostic (Q2 FY27)
Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2
- Unihealth Hosp (Q2 FY27)
1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r
- Sangani Hospital (Q2 FY27)
1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.